Ticker Symbol | Entity Name | As Of Date | Review Url | Logo | Company URL | Company | Author Title | Author Location | Author Country | Summary | Description | PROs | CONs | Helpful Count | Not Helpful Count | Rating: Overall | Rating: Work/Life Balance | Rating: Culture & Values | Rating: Career Opportunities | Rating: Comp & Benefits | Rating: Senior Management | Date Added | Date Updated | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:axon | https://www.indeed.com/cmp/axovant-sciences/reviews | Feb 10th, 2018 12:00AM | Open | Open | Axovant Sciences | Vice President, Payer Access & Reimbursement (Current Employee) | Field Based | Prodcut Development Company | Axovant is full of creative talent in search of an elusive treatment for key areas of neurology. The teams are passionate about fulfilling patient needs and delivering value. | Creative culture | Lack of product development | 0.0 | 0.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | Jan 27th, 2020 12:00AM | Jan 27th, 2020 07:11PM | Axovant Sciences | ||||
nasdaq:axon | https://www.indeed.com/cmp/axovant-sciences/reviews | Feb 10th, 2018 12:00AM | Open | Open | Axovant Sciences | Vice President, Payer Access & Reimbursement | Field Based | Prodcut Development Company | Axovant is full of creative talent in search of an elusive treatment for key areas of neurology. The teams are passionate about fulfilling patient needs and delivering value. | Creative culture | Lack of product development | 0.0 | 0.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | Jan 27th, 2020 12:00AM | Jan 27th, 2020 07:11PM | Axovant Sciences |